Human serum triggers antibiotic tolerance in Staphylococcus aureus
Preprint posted on November 12, 2021 https://www.biorxiv.org/content/10.1101/2021.11.11.468061v1
Context and background: We’ve all used antibiotics at some point in our life. Antibiotics are our first weapon of choice when dealing with bacterial infections, and they have proven to be useful over many years. However, with the current rise in antibiotic resistance, treating such infections has become more and more difficult.
Staphylococcus aureus is one of the most common pathogens causing various infections in humans, including those of the skin, lungs, blood and more. Due to the high prevalence of methicillin resistant S. aureus (MRSA) in infections, vancomycin or daptomycin are recommended as antibiotics for treatment rather than the usual β-lactams used for methicillin sensitive S. aureus infections . Daptomycin works by permeabilising bacterial cell membranes.
While most tests for antibiotic susceptibility are done in laboratory media, these fail to replicate in vivo conditions and the infection microenvironment. Hence, while bacteria may be susceptible to a particular antibiotic in vitro, this may not always reflect in the clinic and can lead to treatment failure.
This preprint looks at how human serum induces tolerance to daptomycin, as well as other antibiotics, in S. aureus in vitro. By identifying a specific peptide in serum that induces this tolerance, the authors show that host factors can influence antibiotic susceptibility.
Experimental setup: An MRSA strain and various mutants of this strain were used in this study. Mutants were generated to identify which two-component systems in MRSA were responsible for serum induced tolerance. Bacteria were grown in either a laboratory broth (tryptic soy broth – TSB) or in human serum. Bacterial viability was quantified from Colony Forming Unit (CFU) counts of bacterial cultures exposed to appropriate antibiotics. Daptomycin was fluorescently labelled to determine binding to S. aureus. Cell membrane characteristics such as polarity and permeability were also determined for serum-adapted bacteria.
Serum incubation increased daptomycin tolerance via reduced binding to S. aureus cells – TSB-grown S. aureus showed a dose and time-dependent killing when exposed to daptomycin. However, over this same period of 6 hours, serum-grown cells were able to completely survive even at 20 and 40 µg/mL, and up to 17% survival at 80 µg/mL of daptomycin. A reduced binding of daptomycin to serum-adapted S. aureus cells as well as reduced cell membrane disruption was seen.
Antimicrobial peptide (AMP) LL-37 in serum activates a two-component system (GraRS) to induce daptomycin tolerance, along with a role for GraRS-independent changes in the cell membrane – Mutant screening helped identify a two-component system (GraRS) that is triggered by an AMP in serum. A GraRS-dependent increase in peptidoglycan in the cell membrane of serum-adapted S. aureus cells. This increased peptidoglycan was seen to play a role in the increased daptomycin tolerance in these cells. An increase in the phospholipid cardiolipin was also seen in serum-adapted cells, and this was independent of GraRS. Combining a cell wall synthesis inhibitor with daptomycin reduced the antibiotic tolerance of serum-adapted cells.
Overall, serum resulted in changes in the cell membrane and cell wall of S. aureus to reduce daptomycin binding and cell membrane disruption, thus conferring daptomycin tolerance to S. aureus. This adds to the current literature that has documented increased tolerance to various antibiotics for different pathogens in the presence of serum (2, 3).
What I found interesting about this preprint: While using standard laboratory broths has advantages, these do not mimic conditions in the human body. This preprint really highlights the importance of incorporating human factors in various in vitro studies of antimicrobial resistance.
Question for the authors: Serum-associated antibiotic tolerance has been shown for other antibiotics as well. In some of these cases, this is due to binding of the antibiotic to proteins in serum, thus reducing the concentration of available antibiotic in the microenvironment. Was this aspect explored for daptomycin in serum?
- Hassoun, Ali, Peter K. Linden, and Bruce Friedman. “Incidence, prevalence, and management of MRSA bacteremia across patient populations—a review of recent developments in MRSA management and treatment.” Critical care1 (2017): 1-10.
- Morrison, John M., et al. “Serum-Associated antibiotic tolerance in pediatric clinical isolates of Pseudomonas aeruginosa.” Journal of the Pediatric Infectious Diseases Society6 (2020): 671-679.
- Li, Jun, et al. “Antimicrobial activity and resistance: influencing factors.” Frontiers in pharmacology8 (2017): 364.
Posted on: 19th November 2021 , updated on: 1st December 2021Read preprint
Also in the microbiology category:
Immunometabolic hijacking of immune cells by a Pseudomonas aeruginosa quorum-sensing signal
|Selected by||Joao Mello-Vieira|
Cellular chaining influences biofilm formation and structure in Group A Streptococcus
|Selected by||SCELSE Summer School|
Interspecies interactions in bacterial colonies are determined by physiological traits and the environment
|Selected by||SCELSE Summer School|
preListsmicrobiology category:in the
BioMalPar XVI: Biology and Pathology of the Malaria Parasite
[under construction] Preprints presented at the (fully virtual) EMBL BioMalPar XVI, 17-18 May 2020 #emblmalaria
|List by||Dey Lab, Samantha Seah|
ECFG15 – Fungal biology
Preprints presented at 15th European Conference on Fungal Genetics 17-20 February 2020 Rome
|List by||Hiral Shah|
EMBL Seeing is Believing – Imaging the Molecular Processes of Life
Preprints discussed at the 2019 edition of Seeing is Believing, at EMBL Heidelberg from the 9th-12th October 2019
|List by||Dey Lab|
Antimicrobials: Discovery, clinical use, and development of resistance
Preprints that describe the discovery of new antimicrobials and any improvements made regarding their clinical use. Includes preprints that detail the factors affecting antimicrobial selection and the development of antimicrobial resistance.
|List by||Zhang-He Goh|